Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
Monocrotaline pyrrole (MCTP) is a reactive metabolite of the pyrrolizidine alkaloid monocrotaline. MCTP given intravenously to rats causes pulmonary hypertension and right ventricular hypertrophy. Lesions in lungs after MCTP treatment contain macrophages and neutrophils, which may contribute to the damage by generation of reactive oxygen metabolites. Rats were treated with MCTP and agents known to protect against oxygen radical-mediated damage in acute models of neutrophil-dependent lung injury. Rats received MCTP and deferoxamine mesylate (DF), dimethyl sulfoxide (DMSO), or polyethylene glycol-coupled catalase (PEG-CAT). MCTP/vehicle-treated controls developed lung injury manifested as increased lung weight, release of lactate dehydrogenase into the airway, and sequestration of 125I-labeled bovine serum albumin in the lungs. Cotreatment of rats with DF, DMSO, or PEG-CAT did not protect against the injury due to MCTP. These results suggest that toxic oxygen metabolites do not play an important role in the pathogenesis of MCTP-induced pulmonary injury.
D000818:Animals; D002374:Catalase / Q000494:pharmacology*; D003676:Deferoxamine / Q000494:pharmacology*; D004121:Dimethyl Sulfoxide / Q000494:pharmacology*; D008168:Lung / Q000187:drug effects / Q000473:pathology*; D008297:Male; D016686:Monocrotaline / Q000031:analogs & derivatives*; D011092:Polyethylene Glycols; D011763:Pyrrolizidine Alkaloids / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains
D011763:Pyrrolizidine Alkaloids; C014114:monocrotaline pyrrole; D011092:Polyethylene Glycols; D016686:Monocrotaline; D002374:Catalase; D003676:Deferoxamine; D004121:Dimethyl Sulfoxide